Howe CS, Chulkina M, Syrcle R, McAninch C, et al. MK2 Inhibition in CD4+ T Cells Protects Against IFNgamma and IL-17A, Chronic Inflammation, and Fibrosis in Inflammatory Bowel Disease Models. Inflamm Bowel Dis 2025 Feb 12:izaf026. doi: 10.1093.
PMID: 39937137